多奈哌齐不良反应的研究进展

摘要/Abstract

摘要： 多奈哌齐是第二代特异的可逆性中枢乙酰胆碱酯酶抑制剂（Acetylcholinesterase inhibitors，AChEIs），主要用于阿尔兹海默症（Alzheimer′s disease，AD）、血管性痴呆等疾病的治疗，临床应用广泛。通过对近年来关于多奈哌齐不良反应的文献进行综述，发现多奈哌齐引起的不良反应主要包括胃肠道反应、心律失常、精神紊乱等，以期为临床合理用药提供参考。

关键词: font-size:medium, ">多奈哌齐；阿尔兹海默症；不良反应；胃肠道反应

Abstract: Donepezil is one of the second-generation specific reversible central acetylcholinesterase inhibitors (AChEIs). It iswidely applicatedin the treatment of Alzheimer′s disease (AD)， vascular dementia and other diseases in clinical practice.In order to provide a scientific basis for clinical applications， this articlesummarized the adverse reactions of donepezil.By reviewing the relevant literature in recent years，it was foundthat the adverse reactions of donepezil weremainly gastrointestinal reactions， arrhythmias and mental disorders.

Key words: font-size:medium, ">Donepezil； Alzheimer′s disease； Adverse reactions； Gastrointestinal reactions

中图分类号:

于飞, 陈佩佩, 李紫璇, 颜久兴. 多奈哌齐不良反应的研究进展[J]. 中国药物评价, 2022, 39(5): 422-426.

YU Fei, CHEN Pei-pei, LI Zi-xuan, YAN Jiu-xing. Research Progress on Adverse Reactions of Donepezil[J]. CHINESE JOURNAL OF DRUG EVALUATION, 2022, 39(5): 422-426.

参考文献

[1]Droogsma E，Van Asselt D，Diekhuis M，et al. Initial cognitive response to cholinesterase inhibitors and subsequent long-term course in patients with mild Alzheimer′s disease[J].Int Psychogeriatr，2015，27(8)：1323-1333.
     [2]喻东山，葛茂宏.精神科合理用药手册[M].第4版.南京：江苏科学技术出版社，2020：480-482.
     [3]Carrasco MM，Aguera L，Gil P，et al. Safety and effectiveness of donepezil on behavioral symptoms in patients with Alzheimer disease[J].Alzheimer Dis Assoc Disord，2011，25(4)：333-340.
     [4]谢洪宝，黄秀月.盐酸多奈哌齐致不良反应35例分析[J].临床合理用药杂志，2017，10(13)：12-15.
     [5]Kok KS，Loke Y，Southgate J. Upper gastrointestinal bleed associated with cholinesterase inhibitor use[J].BMJ Case Rep，2015：bcr2015211859.
     [6]Gust C，Pugliese N，Stern G. Suspected donepezil toxicity： A case report[J].Clin Case Rep，2020，8(12)：2818-2823.
     [7]Kim DH，Brown RT，Ding EL，et al. Dementia medications and risk of falls， syncope， and related adverse events： meta-analysis of randomized controlled trials[J].J Am Geriatr Soc，2011，59(6)：1019-1031.
     [8]Tanaka A，Koga S，Hiramatsu Y. Donepezil-induced adverse side effects of cardiac rhythm： 2 cases report of atrioventricular block and Torsade de Pointes[J].Intern Med，2009，48(14)：1219-1223.
     [9]Kitt J，Irons R，Al-Obaidi M，et al. A case of donepezil-related torsades de pointes[J].BMJ Case Rep2015：bcr2015211900.
     [10]Kho J，Ioannou A，Mandal AKJ，et al. Long term use of donepezil and QTc prolongation[J].Clin Toxicol (Phila)，2021，59(3)：208-214.
     [11]Hadano Y，Ogawa H，Wakeyama T，et al. Donepezil-induced torsades de pointes without QT prolongation[J].J Cardiol Cases，2013，8(2)：e69-e71.
     [12]Morris R，Luboff H，Jose RP，et al. Bradycardia Due to Donepezil in Adults： Systematic Analysis of FDA Adverse Event Reporting System[J].J Alzheimers Dis，2021，81(1)：297-307.
     [13]Jackson EG，Stowe S. Lesson of the month 1： Prolonged QT syndrome due to donepezil： a reversible cause of falls[J].Clin Med (Lond)，2019，19(1)：80-81.
     [14]Takaya T，Okamoto M，Yodoi K， et al. Torsades de Pointes with QT prolongation related to donepezil use[J].J Cardiol，2009，54(3)：507-511.
     [15]吕小琴，胡婷霞，刘赛月，等.240例多奈哌齐致不良反应统计分析[J].中国临床药学杂志，2018，27(5)：346-351.
     [16]Leung JG. Donepezil-induced mania[J].Consult Pharm，2014，29(3)：191-195.
     [17]Hategan A，Bourgeois JA. Donepezil-associated manic episode with psychotic features： a case report and review of the literature[J].Gen Hosp Psychiatry，2016，38：115e1-e4.
     [18]Tourian L Jr，Margolese HC，Gauthier S. Donepezil-associated mania in two patients who were using donepezil without a prescription[J].J Clin Psychopharmacol，2014，34(6)：753-755.
     [19]Decker MW，McGaugh JL. The role of interactions between the cholinergic system and other neuromodulatory systems in learning and memory[J].Synapse，1991，7(2)：151-168.
     [20]Shearman E，Rossi S，Szasz B，et al. Changes in cerebral neurotransmitters and metabolites induced by acute donepezil and memantine administrations： a microdialysis study[J].Brain Res Bull，2006，69(2)：204-213.
     [21]Van Enkhuizen J，Geyer MA， Halberstadt AL， et al. Dopamine depletion attenuates some behavioral abnormalities in a hyperdopaminergic mouse model of bipolar disorder[J].J Affect Disord，2014，155：247-254.
     [22]林琳，瞿发林.抗精神病药所致的锥体外系反应及其防治[J].实用药物与临床，2012，15(2)：115-117.
     [23]Wang HM，Liou LM，Hsu CY，et al. Letter to the editor： Donepezil-induced parkinsonism in end-stage renal disease[J].Neurol Sci，2021，42(11)：4809-4812.
     [24]Li HC，Luo KX，Wang JS，et al. Extrapyramidal side effect of donepezil hydrochloride in an elderly patient： A case report[J].Medicine (Baltimore)，2020，99(11)：e19443.
     [25]Zannas AS，Okuno Y，Doraiswamy PM. Cholinesterase inhibitors and Pisa syndrome： a pharmacovigilance study[J].Pharmacotherapy，2014，34(3)：272-278.
     [26]Mukku SSR，Achary U，Sivakumar PT，et al. Recurrent truncal dystonia (Pisa syndrome) due to donepezil-A case report[J].Asian J Psychiatr，2018，35：47-49.
     [27]巫俊，黄虹.盐酸多奈哌齐诱发锥体外系反应1例[J].人民军医，2009，52(10)：639.
     [28]Grossberg GT. Cholinesterase inhibitors for the treatment of Alzheimer′s disease： getting on and staying on[J].Curr Ther Res，2003，64(4)：216-235.
     [29]Kim D，Yoon HE，Park HS，et al. Development of donepezil-induced hypokalemia following treatment of cognitive impairment[J].Yeungnam Univ J Med，2021，38(1)：65-69.
     [30]McGrane IR，Shuman MD，McDonald RW. Donepezil-related intractable hiccups： a case report[J].Pharmacotherapy，2015，35(3)：e1-e5.
     [31]Sahin OZ，Ayaz T，Yuce S，et al. A rare case of acute renal failure secondary to rhabdomyolysis probably induced by donepezil[J].Case Rep Nephrol 2014，2014：214359.
     [32]Segrec N，Zaman R，Pregelj P. Increased libido associated with donepezil treatment： a case report[J].Psychogeriatrics，2016，16(1)：70-72.
     [33]Pourmand A，Shay C，Redha W，et al. Cholinergic symptoms and QTc prolongation following donepezil overdose[J].Am J Emerg Med，2017，35(9)：1386.e1-1386.e3.
     [34]Bougea A，Gerakoulis S，Anagnostou E，et al. Donepezil-induced myoclonus in a patient with Alzheimer disease[J].Ann Pharmacother，2014，48(12)：1659-1661.
     [35]Vogel SM，Mican LM，Smith TL. Donepezil-induced QTc prolongation： A case report[J].Ment Health Clin，2019，9(3)：128-132.
     [36]Chew AP，Lim WS，Tan KT. Donepezil-induced hepatotoxicity in an elderly adult takingfluoxetine[J].J Am Geriatr Soc，2014，62(10)：2009-2011.
     [37]Marshall K，Fritz K，Thom W，et al. Toxic interaction between fluoxetine and donepezil：a case of cholinergic toxidrome[J].J Neuropsychiatry Clin Neurosci，2012，24(2)：E50.
     [38]Alfaro CL，Lam YW，Simpson J，et al. CYP2D6 inhibition by fluoxetine， paroxetine， sertraline， and venlafaxine in a crossover study： intraindividual variability and plasma concentration correlations[J].J Clin Pharmacol，2000，40(1)：58-66.
     [39]Mican LM，Schulenberg S. In the balance： acase of neuroleptic malignant syndrome when donepezil is added to maintenance haloperidol decanoate[J].J Pharm Technol，2014，30(6)：235-239.
     [40]Kang SH，Kim DK. Drug induced parkinsonism caused by the concurrent use of donepezil and risperidone in a patient with traumatic brain injuries[J].Ann Rehabil Med，2013，37(1)：147-150.
     [41]Wicklund S，Wright M. Donepezil-induced mania[J].J Neuropsychiatry Clin Neurosci，2012，24(3)：E27.